Hao Zeng Selected Research

RNA Polymerase II (RNA Polymerase B)

1/2022	The transcriptional elongation factor CTR9 demarcates PRC2-mediated H3K27me3 domains by altering PRC2 subtype equilibrium.
11/2016	Systematic identification of Ctr9 regulome in ERα-positive breast cancer.
3/2016	Gene expression profiling of Ctr9-regulated transcriptome in ERα-positive breast cancer.
10/2015	Ctr9, a key subunit of PAFc, affects global estrogen signaling and drives ERα-positive breast tumorigenesis.
10/2015	MED12 methylation by CARM1 sensitizes human breast cancer cells to chemotherapy drugs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hao Zeng Research Topics

Disease

87	Neoplasms (Cancer) 05/2024 - 11/2006
67	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 03/2005
37	Infections 02/2024 - 12/2008
24	Renal Cell Carcinoma (Grawitz Tumor) 04/2024 - 01/2009
19	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2011
14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 01/2020
13	Spinal Tuberculosis (Pott's Disease) 01/2023 - 10/2013
11	Adenocarcinoma 10/2023 - 03/2005
10	Sepsis (Septicemia) 09/2023 - 10/2015
10	Pancreatitis 08/2023 - 01/2016
10	Inflammation (Inflammations) 05/2023 - 08/2009
8	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2024 - 09/2015
8	Carcinogenesis 04/2023 - 06/2009
8	Tuberculosis (Tuberculoses) 01/2023 - 01/2015
8	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2013
7	Carcinoma (Carcinomatosis) 04/2024 - 11/2006
7	Staphylococcal Infections 01/2022 - 10/2015
6	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 01/2022
5	Acute Necrotizing Pancreatitis 01/2022 - 01/2017
4	Dry Eye Syndromes (Dry Eye Syndrome) 01/2024 - 01/2021
4	Hypoxia (Hypoxemia) 03/2023 - 04/2009
4	COVID-19 12/2022 - 01/2020
4	Congenital Preauricular Fistulae 01/2022 - 10/2015
4	Disease Progression 12/2021 - 09/2015
4	Bacteremia 01/2021 - 12/2015
4	Pneumonia (Pneumonitis) 01/2021 - 02/2016
4	Wounds and Injuries (Trauma) 01/2021 - 07/2010
4	Kyphosis 01/2018 - 11/2015
3	Osteosarcoma (Osteogenic Sarcoma) 05/2024 - 01/2020
3	Kidney Neoplasms (Kidney Cancer) 03/2024 - 01/2023
3	Reperfusion Injury 11/2023 - 01/2019
3	Hyperthermia 12/2022 - 06/2018
3	Wound Infection (Wound Infections) 09/2022 - 01/2018
2	Extranodal Extension 04/2024 - 12/2023
2	Malignant Pleural Effusion 03/2024 - 02/2024
2	Stomach Neoplasms (Stomach Cancer) 03/2024 - 10/2012
2	Rectal Neoplasms (Rectal Cancer) 03/2024 - 12/2023

Drug/Important Bio-Agent (IBA)

30	Proteins (Proteins, Gene)FDA Link 02/2024 - 11/2002
27	VaccinesIBA 10/2023 - 01/2012
20	Biomarkers (Surrogate Marker)IBA 05/2023 - 11/2006
13	AntigensIBA 01/2023 - 03/2005
12	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 01/2013
11	AndrogensIBA 10/2020 - 07/2010
10	abirateroneIBA 04/2024 - 08/2017
10	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2021
10	Tyrosine Kinase InhibitorsIBA 03/2024 - 01/2019
9	Hormones (Hormone)IBA 06/2023 - 01/2010
8	Transcription Factors (Transcription Factor)IBA 05/2024 - 04/2009
8	Messenger RNA (mRNA)IBA 02/2024 - 01/2013
8	C-Reactive ProteinIBA 09/2023 - 01/2015
7	RNA (Ribonucleic Acid)IBA 05/2024 - 01/2020
7	Docetaxel (Taxotere)FDA Link 01/2024 - 08/2017
7	EnzymesIBA 01/2023 - 11/2007
7	MicroRNAs (MicroRNA)IBA 01/2023 - 10/2017
7	Peptides (Polypeptides)IBA 01/2022 - 07/2010
6	DNA (Deoxyribonucleic Acid)IBA 05/2024 - 01/2013
6	Therapeutic UsesIBA 02/2024 - 02/2016
6	EpitopesIBA 01/2022 - 01/2019
6	Sunitinib (Sutent)FDA Link 01/2021 - 01/2009
5	Sorafenib (BAY 43-9006)FDA Link 10/2023 - 07/2010
5	RNA Polymerase II (RNA Polymerase B)IBA 01/2022 - 10/2015
5	coactivator-associated arginine methyltransferase 1IBA 11/2017 - 05/2013
4	Fumarate Hydratase (Fumarase)IBA 03/2024 - 01/2021
4	AntibodiesIBA 11/2023 - 11/2013
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2024 - 01/2012
3	enzalutamideIBA 01/2024 - 01/2020
3	Vancomycin FDA LinkGeneric 12/2023 - 02/2016
3	CateninsIBA 03/2023 - 10/2018
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2019
3	Alkaline PhosphataseIBA 01/2023 - 12/2018
3	LigandsIBA 01/2023 - 06/2010
3	Phosphotransferases (Kinase)IBA 01/2023 - 04/2007
3	Dexamethasone (Maxidex)FDA LinkGeneric 03/2022 - 02/2016
3	ChromatinIBA 01/2022 - 04/2009
3	Apoptosis Regulatory ProteinsIBA 05/2021 - 04/2009
3	Indicators and Reagents (Reagents)IBA 01/2021 - 05/2016
3	Interleukin-17 (Interleukin 17)IBA 03/2018 - 10/2012
3	CytokinesIBA 03/2018 - 06/2010
3	ElementsIBA 01/2017 - 11/2007
3	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 01/2016 - 01/2014
3	SurvivinIBA 07/2010 - 11/2006
2	ErbB Receptors (EGF Receptor)IBA 04/2024 - 01/2019
2	Circulating Tumor DNAIBA 04/2024 - 01/2023

Therapy/Procedure

55	Therapeutics 04/2024 - 11/2007
28	Castration 01/2024 - 09/2010
19	Drug Therapy (Chemotherapy) 05/2024 - 08/2015
15	Radiotherapy 04/2024 - 03/2006
14	Immunotherapy 05/2024 - 10/2015
14	Debridement 03/2020 - 10/2013
11	Prostatectomy (Retropubic Prostatectomy) 04/2024 - 01/2012
5	Bone Transplantation (Bone Grafting) 03/2020 - 06/2015
4	Nephrectomy 04/2024 - 01/2012
4	Length of Stay 02/2024 - 12/2017
4	Curettage 01/2020 - 01/2019
4	Decompression 04/2016 - 01/2015
3	Catheters 02/2024 - 01/2017
3	Cystectomy 01/2024 - 01/2012
3	Lasers (Laser) 12/2022 - 03/2016
3	Lymph Node Excision (Lymph Node Dissection) 01/2020 - 05/2016
2	Metastasectomy 04/2024 - 08/2018